M&A

News

Rumour confirmed as Mallinckrodt merges with Endo

Two pharmas that filed for bankruptcy protection due to opioid litigation in the US – Mallinckrodt and Endo – are rumoured to be in merger talks.

News

BMS absorbs CAR-T partner 2seventy bio for $286m

Bristol Myers Squibb has moved to take full control of the CAR-T therapy it partners with 2seventy bio, agreeing to buy the biotech for around $286m.

News

Sun Pharma buys Checkpoint and its new cancer drug

Sun Pharma has agreed to acquire Checkpoint Therapeutics, which recently claimed FDA approval for its first drug but is also running short on cash.

News

Digital health firm XRHealth hits the M&A trial again

XRHealth has made its second acquisition in the space of a few months, buying digital therapeutics (DTx) company RealizedCare.

News

Jazz swings further into cancer with Chimerix takeover

Jazz has reached an agreement to buy Chimerix for around $935 million, adding a brain cancer drug heading for an FDA approval decision in August.

News

Troubled gene therapy player bluebird sold for a song

At risk of defaulting on financial commitments, gene therapy firm bluebird bio has agreed to sell itself to private equity firms at a knockdown price.

Rumour confirmed as Mallinckrodt merges with Endo

BMS absorbs CAR-T partner 2seventy bio for $286m

Sun Pharma buys Checkpoint and its new cancer drug

Digital health firm XRHealth hits the M&A trial again

Jazz swings further into cancer with Chimerix takeover

Troubled gene therapy player bluebird sold for a song

ADARx, Trex, and Retension take aim at IPOs

Discover a new era of healthcare panel engagement: Grounded ...

M&A

Editor's Picks